European public health authorities report more than 1,000 locally acquired human cases of the West Nile virus across 15 countries as of September 2024, reflecting a sharp seasonal acceleration driven by mosquito transmission. According to data released by the European Centre for Disease Prevention and Control (ECDC), 1,086 locally contracted infections have been registered across seven primary nations, marking a steep climb from just 241 cases reported in early August.
Geographic Spread and Hard-Hit Regions in Europe
Italy, Greece, and Spain bear the heaviest burden of the 2024 transmission season. According to ECDC surveillance updates, Italy leads the continent with 516 confirmed local cases distributed across 144 affected areas, followed closely by Greece with 284 cases—including 11 infections of unknown origin—and Spain with 88 cases. Additional local infections are documented in Germany, Austria, France, and the Netherlands. The virus now circulates across 144 distinct territorial units in Europe, with 62 of those affected zones located inside Italy alone. ECDC officials caution that these totals do not represent a comprehensive mapping of the entire transmission landscape, as many asymptomatic infections go untested.
Clinical Presentation and Transmission Dynamics
The West Nile virus cycles primarily between wild bird populations and mosquitoes, which occasionally bite and infect humans. According to the Robert Koch Institute (RKI), roughly 20 percent of infected individuals develop a mild, febrile, influenza-like illness characterized by sudden fever, headaches, and body aches. Severe neurological disease occurs in approximately one out of every 100 infections. While standard West Nile fever typically resolves completely without long-term medical complications, patients who develop severe neuroinvasive disease frequently experience persistent neurological sequelae, according to public health guidelines.